Global Postoperative Nausea and Vomiting (PONV) Market Research Report 2023

Report ID: 1994689 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Serotonin Antagonists
        1.2.3 Steroids
        1.2.4 Dopamine Antagonists
        1.2.5 NK-1 Receptor Antagonists
        1.2.6 Non-pharmacologic Treatment
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2018-2029)
    2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Region
        2.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2018-2023)
        2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2024-2029)
    2.3 Postoperative Nausea and Vomiting (PONV) Market Dynamics
        2.3.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
        2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
        2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
        2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue
        3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2018-2023)
        3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2018-2023)
    3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
    3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
        3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2022
    3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
    3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
    3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type
    4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2018-2023)
    4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2024-2029)
5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application
    5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2018-2023)
    5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
    6.2 North America Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
    6.4 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
    7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
    7.4 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
    8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2023)
    8.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
    9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
    9.4 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2018-2029)
    10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
    10.4 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Acacia Pharma
        11.1.1 Acacia Pharma Company Detail
        11.1.2 Acacia Pharma Business Overview
        11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
        11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.1.5 Acacia Pharma Recent Development
    11.2 F. Hoffmann-La Roche
        11.2.1 F. Hoffmann-La Roche Company Detail
        11.2.2 F. Hoffmann-La Roche Business Overview
        11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
        11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.2.5 F. Hoffmann-La Roche Recent Development
    11.3 Novartis
        11.3.1 Novartis Company Detail
        11.3.2 Novartis Business Overview
        11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
        11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.3.5 Novartis Recent Development
    11.4 Ani Pharmaceuticals
        11.4.1 Ani Pharmaceuticals Company Detail
        11.4.2 Ani Pharmaceuticals Business Overview
        11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
        11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.4.5 Ani Pharmaceuticals Recent Development
    11.5 Camurus
        11.5.1 Camurus Company Detail
        11.5.2 Camurus Business Overview
        11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
        11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.5.5 Camurus Recent Development
    11.6 Sanofi
        11.6.1 Sanofi Company Detail
        11.6.2 Sanofi Business Overview
        11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
        11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.6.5 Sanofi Recent Development
    11.7 Helsinn Holding
        11.7.1 Helsinn Holding Company Detail
        11.7.2 Helsinn Holding Business Overview
        11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
        11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.7.5 Helsinn Holding Recent Development
    11.8 Eisai
        11.8.1 Eisai Company Detail
        11.8.2 Eisai Business Overview
        11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
        11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.8.5 Eisai Recent Development
    11.9 Merck
        11.9.1 Merck Company Detail
        11.9.2 Merck Business Overview
        11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
        11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.9.5 Merck Recent Development
    11.10 GlaxoSmithKline
        11.10.1 GlaxoSmithKline Company Detail
        11.10.2 GlaxoSmithKline Business Overview
        11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
        11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
        11.10.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Serotonin Antagonists
    Table 3. Key Players of Steroids
    Table 4. Key Players of Dopamine Antagonists
    Table 5. Key Players of NK-1 Receptor Antagonists
    Table 6. Key Players of Non-pharmacologic Treatment
    Table 7. Key Players of Others
    Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2018-2023)
    Table 12. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2024-2029)
    Table 14. Postoperative Nausea and Vomiting (PONV) Market Trends
    Table 15. Postoperative Nausea and Vomiting (PONV) Market Drivers
    Table 16. Postoperative Nausea and Vomiting (PONV) Market Challenges
    Table 17. Postoperative Nausea and Vomiting (PONV) Market Restraints
    Table 18. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players (2018-2023)
    Table 20. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2022)
    Table 21. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
    Table 25. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2018-2023)
    Table 29. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2024-2029)
    Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2018-2023)
    Table 33. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2024-2029)
    Table 35. North America Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Acacia Pharma Company Detail
    Table 51. Acacia Pharma Business Overview
    Table 52. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product
    Table 53. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 54. Acacia Pharma Recent Development
    Table 55. F. Hoffmann-La Roche Company Detail
    Table 56. F. Hoffmann-La Roche Business Overview
    Table 57. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product
    Table 58. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 59. F. Hoffmann-La Roche Recent Development
    Table 60. Novartis Company Detail
    Table 61. Novartis Business Overview
    Table 62. Novartis Postoperative Nausea and Vomiting (PONV) Product
    Table 63. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 64. Novartis Recent Development
    Table 65. Ani Pharmaceuticals Company Detail
    Table 66. Ani Pharmaceuticals Business Overview
    Table 67. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product
    Table 68. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 69. Ani Pharmaceuticals Recent Development
    Table 70. Camurus Company Detail
    Table 71. Camurus Business Overview
    Table 72. Camurus Postoperative Nausea and Vomiting (PONV) Product
    Table 73. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 74. Camurus Recent Development
    Table 75. Sanofi Company Detail
    Table 76. Sanofi Business Overview
    Table 77. Sanofi Postoperative Nausea and Vomiting (PONV) Product
    Table 78. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 79. Sanofi Recent Development
    Table 80. Helsinn Holding Company Detail
    Table 81. Helsinn Holding Business Overview
    Table 82. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product
    Table 83. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 84. Helsinn Holding Recent Development
    Table 85. Eisai Company Detail
    Table 86. Eisai Business Overview
    Table 87. Eisai Postoperative Nausea and Vomiting (PONV) Product
    Table 88. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 89. Eisai Recent Development
    Table 90. Merck Company Detail
    Table 91. Merck Business Overview
    Table 92. Merck Postoperative Nausea and Vomiting (PONV) Product
    Table 93. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 94. Merck Recent Development
    Table 95. GlaxoSmithKline Company Detail
    Table 96. GlaxoSmithKline Business Overview
    Table 97. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product
    Table 98. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
    Table 99. GlaxoSmithKline Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2022 VS 2029
    Figure 3. Serotonin Antagonists Features
    Figure 4. Steroids Features
    Figure 5. Dopamine Antagonists Features
    Figure 6. NK-1 Receptor Antagonists Features
    Figure 7. Non-pharmacologic Treatment Features
    Figure 8. Others Features
    Figure 9. Global Postoperative Nausea and Vomiting (PONV) Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2022 VS 2029
    Figure 11. Hospital Pharmacies Case Studies
    Figure 12. Online Pharmacies Case Studies
    Figure 13. Retail Pharmacies Case Studies
    Figure 14. Postoperative Nausea and Vomiting (PONV) Report Years Considered
    Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region: 2022 VS 2029
    Figure 18. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2022
    Figure 19. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2022)
    Figure 20. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2022
    Figure 21. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. North America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2029)
    Figure 23. United States Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2029)
    Figure 27. Germany Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2018-2029)
    Figure 35. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. South Korea Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Australia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2029)
    Figure 43. Mexico Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Brazil Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2029)
    Figure 47. Turkey Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 51. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 52. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 53. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 54. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 55. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 56. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 57. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Acacia Pharma
F. Hoffmann-La Roche
Novartis
Ani Pharmaceuticals
Camurus
Sanofi
Helsinn Holding
Eisai
Merck
GlaxoSmithKline
Frequently Asked Questions
Postoperative Nausea and Vomiting (PONV) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Postoperative Nausea and Vomiting (PONV) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Postoperative Nausea and Vomiting (PONV) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Constipation

This report aims to provide a comprehensive presentation of the global market for Constipation, w ... Read More

Continence Care

This report aims to provide a comprehensive presentation of the global market for Continence Care ... Read More

Depressive Disorder

This report aims to provide a comprehensive presentation of the global market for Depressive Diso ... Read More